Onderneming Biodel Inc Nasdaq
Aandelen
US09064M1053
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
2023 | Ipsen: overname van Albireo Pharma afgerond | CF |
2023 | Franse geneesmiddelenproducent Ipsen sluit overname Albireo Pharma af | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 60 | 08-12-03 | |
President | 57 | 02-03-23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13-04-21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02-03-23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02-03-23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04-11-19 |
Muffy Carter
LAW | General Counsel | 71 | 29-11-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 55 | 02-03-23 | |
Director/Board Member | 62 | 02-03-23 | |
Alan Sokaler
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Bedrijfsgegevens
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,13% | 122 mld. | |
+19,65% | 113 mld. | |
+18,25% | 26,49 mld. | |
-23,84% | 19,4 mld. | |
-18,65% | 16,24 mld. | |
-19,28% | 15,4 mld. | |
-45,95% | 15,15 mld. | |
+63,81% | 14,93 mld. | |
+1,94% | 13,52 mld. |
- Beurs
- Aandelen
- Koers ALBO
- Koers
- Onderneming Biodel Inc